Developing Microphysiological Systems for Use as Regulatory Tools - Challenges and Opportunities

被引：27

作者：

Andersen, Melvin E. ^{[1
]}

Betts, Kellyn

Dragan, Yvonne ^{[2
]}

Fitzpatrick, Suzanne ^{[3
]}

Goodman, Jesse L. ^{[4
]}

Hartung, Thomas ^{[5
]}

Himmelfarb, Jonathan ^{[6
]}

Ingber, Donald E. ^{[7
]}

Jacobs, Abigail ^{[8
]}

Kavlock, Robert ^{[9
]}

Kolaja, Kyle ^{[10
]}

Stevens, James L. ^{[11
]}

Tagle, Dan ^{[12
]}

Taylor, D. Lansing ^{[13
]}

Throckmorton, Douglas ^{[8
]}

机构：

[1] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA

[2] AstraZeneca, Waltham, MA USA

[3] US FDA, Ctr Food Safety & Appl Nutr, Silver Spring, MD USA

[4] US FDA, Silver Spring, MD USA

[5] Johns Hopkins Univ, Ctr Alternat Anim Testing, Baltimore, MD USA

[6] Univ Washington, Kidney Res Inst, Seattle, WA USA

[7] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA

[8] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[9] US EPA, Res Triangle Pk, NC USA

[10] Cellular Dynamics Int Inc, Madison, WI USA

[11] Lilly Res Labs, Greenfield, IN 46140 USA

[12] Natl Ctr Adv Translat Sci, NIH, Bethesda, MD USA

[13] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA

来源：

关键词：

CHIP;

D O I：

10.14573/altex.1405151

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：364 / 367

页数：4

共 6 条